The court recently denied the petition to hear a case that would have helped offer clarity on what evidence whistleblowers need to file qui tam lawsuits under the FCA.
National Lab Reporter
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for access to
Articles and Reports
The US has taken its first steps to establish legal limits over AI use by publishing a voluntary code to ensure responsible corporate use of AI.
With temporary waivers of restriction relating to telehealth likely to end soon, here’s a roundup of the current state of state telehealth licensing law.
Loss of constitutional abortion rights undermines privacy protection of patients seeking reproductive care.
The new report could be a turning point in the battle to curb payor abuse of preauthorization requirements.
While the report’s most significant findings involved labs and lab testing, it wasn’t just the usual finger pointing this time.
Federal San Jose jury finds ex-Theranos COO guilty of all 10 ten counts of wire fraud and two counts of conspiracy to commit wire fraud.
After years of resistance, the lab industry’s hopes and prayers for relief from the flawed pricing scheme may soon be answered.
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
Here are the two key CLFS changes, set to take effect on July 1, 2022, that your billing staff needs to know about.
If your lab received federal relief funds from the US government during the COVID-19 pandemic, you could be at risk of FCA lawsuits.
The most recent congressional effort to pass LDT legislation may prove to be the one that finally comes to fruition.
Unsurprisingly, the American Hospital Association and other industry groups don’t think that increase is anywhere near adequate.